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Many Helicobacter pylori genetic studies would benefit from an ability to move DNA sequences easily between
strains by transformation and homologous recombination, without needing to leave a conventional drug
resistance determinant at the targeted locus. Presented here is a two-gene cassette that can be selected both
(i) against, due to a Campylobacter jejuni rpsL gene (dominant streptomycin susceptibility in cells also carrying
an rpsL-strr allele), and (ii) for, due to an erm gene (erythromycin resistance). This rpsL,erm cassette’s utility
was assessed by using it to replace four gene loci (mdaB, frxA, fur, and nikR) in four streptomycin-resistant
[Strr] strain backgrounds (derivatives of 26695, SS1, X47, and G27MA). The resultant 16 strains (phenotyp-
ically erythromycin resistant [Ermr] and Strs) were each transformed with wild-type genomic DNAs, and Strr
derivatives were selected. The desired Erms Strr isolates were obtained at frequencies that ranged from 17 to
96% among Strr transformants, with the Erms yield apparently depending on the strain background and
genome location of the targeted locus. The ease of isolating unmarked transformants described here should be
valuable for many H. pylori molecular genetic and evolutionary analyses.
Genetic studies of the gastric pathogen Helicobacter pylori
(21) often entail (i) the construction of cloned DNAs or PCR
products containing a drug resistance determinant inserted
into or near a gene of interest, (ii) DNA transformation, and
(iii) selection for resistant transformants, which arise by ho-
mologous recombination and replacement of recipient DNA
sequences by corresponding sequences from donor DNA. Al-
though this strategy has been used in hundreds of H. pylori
studies, successfully overcoming the rarity of natural transfor-
mation events, it becomes seriously limiting or flawed in at
least four interesting situations, in each case because transfor-
mants retain resistance determinants at targeted loci: (i) if
changes at numerous loci in the same strain are needed, e.g., in
studies of phenotypes determined by multiple genes with ad-
ditive or redundant effects (because only a few selectable re-
sistance markers are available for H. pylori); (ii) if donor resis-
tance determinants might affect downstream gene expression,
or cellular physiology more generally (e.g., in many cases the
resistance enzymes use cellular metabolites to modify anti-
biotics and thereby confer resistance to them [9]); (iii) if alleles
with subtle (e.g., point mutation) differences are to be com-
pared; or (iv) if alleles from many strains are to be studied in
a common genetic background. Such limitations can be over-
come by using a recipient strain that contains a contraselect-
able marker at the locus of interest. This allows the desired
transformants to be selected by the loss of this recipient
marker, thereby bypassing the need for a conventional resis-
tance determinant in donor DNA.
Three genes that have been used for contraselection in other
systems are thyA (thymidylate requirement; trimethoprim sen-
sitivity) (4, 34), sacB (sucrose sensitivity) (5, 27, 33), and rpsL
(streptomycin sensitivity) (25, 33). H. pylori is naturally tri-
methoprim resistant. This could be ascribed to (i) its apparent
lack of a thyA gene (based on BLASTP homolog searches
[31]); (ii) an intrinsic resistance of its enzyme for reduced
folate synthesis, an apparent dihydrofolate reductase-dihy-
dropteroate synthase chimaera (18); and/or (iii) other factors.
An early report had indicated that sacB could serve as a con-
traselectable marker in H. pylori but did not describe the de-
tails of efficiency or complications that may have been encoun-
tered (8). In our H. pylori sacB experiments, however, selection
for resistance to a range of sucrose concentrations gave far
more background growth of nominally sensitive cells than was
expected based on Escherichia coli experiences (33, 34), and
conditions for sucrose-based differential killing of sacB-con-
taining H. pylori cells varied among trials (unpublished data).
Other groups had also found contraselection of sacB to be
difficult in H. pylori although better than having no such
marker at all (T. L. Cover, unpublished data; R. Haas, unpub-
lished data). A third contraselection strategy, implemented
here, uses the rpsL (ribosomal protein S12) gene and is based
on the dominance of wild-type streptomycin-sensitive (Strs)
alleles to resistance-conferring mutant alleles (16, 25).
Historically, streptomycin killing has been associated with
diverse effects, including membrane damage and irreversible
streptomycin uptake. Paradoxically, these were all blocked by
the bacteriostatic translation inhibitor chloramphenicol. This
implicated the capacity to synthesize proteins, even though
streptomycin also inhibited protein synthesis. Sublethal strep-
tomycin concentrations suppressed nonsense mutations, in-
creased mutation, and caused membrane fragility. Biochemical
studies showed that streptomycin allowed the continuation of
translation once begun, but with errors in translation (misread-
ing), and that it also allowed ribosomes to bind to mRNAs but
blocked them from initiating translation (10). Davis’ early uni-
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fying explanation for streptomycin’s lethality (10) focused on
errors it induced during translation and a resultant accumula-
tion of defective proteins. He focused in particular on mem-
brane proteins, interpreting that defects in them were respon-
sible for the disruption of cell membrane integrity, massive
leakage of ions and molecules, and cell death. This could
explain the dominance of streptomycin sensitivity over resis-
tance, as could the binding of Strs ribosomes to mRNAs, block-
ing the access of resistant ribosomes to these mRNAs, failure
to translate them, and their ensuing degradation (10).
Recent exquisitely detailed molecular and genetic analyses
provide mechanistic understanding. Streptomycin binds sev-
eral specific 16S rRNA loops and thereby diminishes ribosome
flexibility and the changes in conformation that charged tRNA
binding normally induces. It stabilizes a “ribosomal ambiguity”
(ram) state in which there is little if any of the proofreading
needed for error-free protein synthesis (7, 15, 22, 24). Protein
S12, which is mutated in Strr strains, binds rRNA sequences
near sites of streptomycin binding. Most positions in which
change confers resistance are in S12 domains that interact with
the rRNA target. In addition, most Strr mutant S12 proteins
increase the accuracy of translation, apparently by destabilizing
the ram state that streptomycin itself induces; the most ex-
treme of such rpsL (S12) alleles make growth streptomycin
dependent. This can be overcome by mutations in ribosomal
proteins S4 and S5, that in turn stabilize the ram state in this
dynamic and finely tuned ribonucleoprotein machine (7, 14).
The two S12 residues that are most frequently changed in
streptomycin-resistant H. pylori are Lys43 (Lys42 in E. coli
numbering), which contacts the rRNA-bound streptomycin di-
rectly, and Lys88 (Lys87 in E. coli numbering), which is nearby
in the structure (7, 14, 32). Although the Lys-to-Arg changes at
these codons seem to be quite innocuous (14), other amino
acid replacements can markedly diminish bacterial fitness. In
particular, a large fitness cost and a resulting selection for
compensatory mutations in other genes have been documented
in E. coli and Salmonella enterica serovar Typhimurium using
strains with Lys42 replaced with Asn (19, 26) (not Arg). More
critically, the Lys88Arg replacement used here, and also the
Lys43Arg allele, have each been incorporated into H. pylori
strains used for mouse infections, without obvious negative
effects on fitness (12, 13, 23).
Streptomycin contraselection for chromosomal gene re-
placement had been developed for H. pylori previously (13) but
has not been much used, perhaps because very few of the Strr
isolates recovered after transformation had sustained the de-
sired replacement. This, we suspected, was due to the near
identity of the strs and strr H. pylori rpsL alleles used: frequent
gene conversion between them would result in unwanted Strr
gene convertants vastly outnumbering the desired Strr trans-
formants. If correct, it seemed that the rpsL gene might still be
useful for H. pylori genetic engineering if the rpsL gene con-
version could be reduced.
Generalized recombination (gene conversion included) de-
pends on close matches between participating DNA molecules
and is reduced by sequence divergence, even in species that,
like H. pylori, lack the ability to cleave mismatch-containing
(heteroduplex) DNAs (11, 20, 31). The rpsL genes of H. pylori
and Campylobacter jejuni differ by some 18% in overall DNA
sequence, but the encoded S12 proteins are 95% similar in
amino acid sequence. The present study was initiated with an
expectation or hope that H. pylori ribosomes containing the C.
jejuni S12 protein would be functional and Strs and that DNA
sequence divergence between the rpsL genes of C. jejuni and
H. pylori would diminish gene conversion sufficiently for the
effective recovery of transformants by streptomycin contras-
election. The rpsL,erm (streptomycin susceptibility, erythromy-
cin resistance) cassette that we constructed and tested in these
studies is diagrammed in Fig. 1.
MATERIALS AND METHODS
H. pylori strains and general methods. The H. pylori strains used here were
cultured at 37C in a standard microaerobic (5% O2, 10% CO2) atmosphere on
brain heart infusion-horse blood agar plates, with 0.4% Isovitalex and the anti-
biotics amphotericin B (8 g/ml), trimethoprim (5 g/ml), and vancomycin (6
g/ml). Erythromycin (10 g/ml) and streptomycin (10 g/ml) were added to this
agar as needed to select for transformants or screen colonies for resistance to
either drug. Natural transformation was carried out by adding 1 g of genomic
DNA or PCR product to a lawn of cells growing exponentially on nonselective
medium and, after overnight incubation, restreaking the population on selective
(streptomycin- or erythromycin-containing) medium to obtain transformant col-
onies. Standard methods were used for PCR and for sequencing of the PCR
products (2, 30).
Four unrelated H. pylori strains were used here, each chosen because it is much
used in other molecular genetic studies: the genome-sequenced reference strain
26695 (31), which we use to identify the numerous genes that contribute to
high-level metronidazole resistance (2); unrelated strains SS1 and X47 (X47 was
originally called X47-2AL) (12, 17), which colonize mice, preferentially occupy
different regions of the stomach (1, 28), and differ in the phenotypic conse-
quences of inactivation of at least certain metabolic genes (30); and G27MA, a
cell-culture-adapted derivative of the G27 strain that is frequently used for
studies of H. pylori-host cell interaction (3) and that can efficiently colonize
DBA/2 mice (W.-K. Lee, D. Dailidiene, and D. E. Berg, unpublished data). The
erm gene used in the rpsL,erm cassette (Fig. 1) was originally from plasmid
pRH151, kindly provided by Rainer Haas, and was matched in sequence to that
of pNE131 (GenBank accession no. NC_001390). The C. jejuni rpsL gene used in
this cassette was from plasmid pDRF265, kindly provided by David Hendrixson
and Victor DiRita.
To prepare for the development and testing of the rpsL,erm cassette, an strr
allele of the normal chromosomal H. pylori rpsL gene was constructed and
introduced into strain 26695 to generate 26695-str. This was achieved by PCR of
rpsL DNA from 26695 with the primers rpsL1 and rpsL2 (Table 1) to generate
a 203-bp PCR product that contained the A-to-G changes at each of the two sites
most frequently responsible for streptomycin resistance (codons 43 and 88; Lys
to Arg in each case) (32). This product was used to transform strain 26695 to
streptomycin resistance to generate “26695-str.” PCR-based DNA sequencing
showed that each of several such 26695-str transformants contained an A-to-G
change at nucleotide position 263 but was wild type at nucleotide position 129
(i.e., a change of Lys to Arg at codon 88 only). Genomic DNA from one such
transformant was used to transform SS1 and G27MA to streptomycin resistance
(generating SS1-str and G27MA-str). Strain X47 is already streptomycin resis-
tant (10) and was found to contain the same rpsL A263G (Lys88Arg) allele.
PCR-based construction of strains with insertion and deletion alleles. The
alleles used here were constructed by assembling individual PCR products with-
out the need for recombinant DNA plasmid cloning, as first described by Chalker
et al. (6). In brief, assembly depends on overlaps of 20 bp at the ends of DNAs
FIG. 1. Structure of the 1.5-kb rpsL,erm cassette, which confers
dominant streptomycin susceptibility and selectable erythromycin re-
sistance. Open boxes designate open reading frames; solid line indi-
cates noncoding sequences. The cassette contains 272 bp of C. jejuni
sequence upstream of the C. jejuni rpsL gene (408 bp), a 145-bp spacer,
and then the 735-nucleotide erm gene.
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TABLE 1. PCR primers used in this study and features of their amplification products
Process Primera Sequence (5-3)b Product size and/or comments
Creation of streptomycin resistance
allele (strr) of H. pylori rpsL gene
rpsL1 AGGGGTTTGTACTAGGGTTTATACGACTAC
CCCTAAGAAGCCTAACTCG-3
203 bp; the rpsL fragment containing the Lys43Arg
mutation (AAA129AGA) strr allele in primer rpsL1
and the Lys88Arg mutation (AAG263AGG) strr
allele in rpsL2 are shown (mutations are in boldface)
rpsL2 GAACGATGTGGTATTTCACACCGGGTAAAT
CCCTAACCCTACCCCCACG-3
H. pylori rpsL gene sequencing rpsL-F GGGAACAGGCATGTATAAGA-3 675 bp
rpsL-R CGTCGAACATCATCTTATTGAT-3
erm gene amplification from
plasmid pRH151
erm-F CAATAATCGCATCAGATTGCAGTA-3 853 bp; the 5 ends of the erm-F and erm-R primers
are 118 bp upstream of the 5 end and exactly at the
3 end of the erm open reading frame
erm-R TTACTTATTAAATAATTTATAGCTATTGAA-3
mdaB-erm allele construction 1. m1 CCTTCTACCATTAAAATGTAATTG-3 454 bp
2. mermF1 TACTGCAATCTGATGCGATTATTGCTAATTAAG
GAGTGGTCATGTTC-3






All The 5 ends of primers are as follows: primer 1, 596 bp
upstream of the 5 end of mdaB; primer 2, 165 bp
upstream of the 5 end of mdaB; primer 5, 62 bp
downstream of the 3 end of mdaB; primer 6, 563 bp
downstream of the 3 end of mdaB; the PCR
products with primers 1 and 6 are 1,744 and 1,833
bp long from the wild-type and mdaB-erm DNAs,
respectively
mdaB-rpsL,erm allele construction
(C. jejuni rpsL insertion in the
mdaB-erm allele)







5. erm-F CAATAATCGCATCAGATTGCAGTA-3 1,379 bp
6. m4 GAGCTTATGGAAGAATACAGCTCCTTG-3
All The PCR products with primers 1 and 6 are 1,744 and
2,518 bp long from the wild-type and mdaB-rpsL,erm
DNAs, respectively; primers 3 and 4 were used for
amplification of the C. jejuni rpsL gene from plasmid
DRH265; the 5 ends of primers 3 and 4 are 273 bp
upstream of the 5 end and 27 bp downstream of the
3 end of the rpsL open reading frame
nikR-rpsL,erm allele construction
(replacement of nikR with the
rpsL,erm cassette)
1. 1338A1-F TAATAAGCCCACATAAGGCGCG-3 547 bp
2. 1338A2-R TGTTTAATCCATAGTTATAAAGCATCATCCTTT
TTTGGCATGAGTTCG-3






All The 5 ends of the primers are as follows: primer 1,
556 bp upstream of the 5 end of nikR; primer 2, 10
bp upstream of the 5 end of nikR; primer 5, inside
nikR, 54 bp from the 3 end; primer 6, 427 bp
downstream of the 3 end of nikR; the PCR products
with primers 1 and 6 are 1,430 and 2,567 bp long
from the wild-type and nikR-rpsL,erm DNAs,
respectively
frxA-rpsL,erm allele construction
(replacement of frxA with the
rpsL,erm cassette)
1. frxA1-F GTGCGCTTCAAAGCTTGGGTTA-3 444 bp
2. frxA2-R GTGTTTAATCCATAGTTATAAAGCATCGCAACC
ACTTGTTCTCTGTCCA-3






All The 5 ends of the primers are as follows: primer 1,
421 bp upstream of the 5 end of frxA; primer 2,
within frxA, 23 bp from its 5 end; primer 5, 36 bp
downstream of the 3 end of frxA; primer 6, 311 bp
downstream of the 3 end of frxA; the PCR products
with primers 1 and 6 are 1,386 and 2,258 bp long
from the wild-type and frxA-rpsL,erm DNAs,
respectively
Continued on facing page
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to be joined together, which, in turn, result from the design of PCR primers used
in amplification (see Table 1, sequences in italics) (6, 29).
To construct the rpsL,erm cassette, we first replaced the mdaB quinone re-
ductase gene in the H. pylori chromosome with the erm gene and then used
genomic DNA carrying this mdaB-erm allele for PCR to insert the C. jejuni rpsL
gene just upstream of erm. Each of these manipulations involved a three-frag-
ment assembly as in Fig. 2, transformation and selection for erythromycin resis-
tance (Ermr), and PCR verification of structure. Two sequential three fragment
assemblies were used because three-fragment assemblies have been more reli-
able for us than four-fragment assemblies.
In detail, for the first stage (and using the nomenclature presented in Fig. 2)
PCR products were generated with primers 1 and 2 (fragment A, upstream of
mdaB), primers 5 and 6 (fragment C, downstream of mdaB), and primers 3 and
4 (fragment B, erm) (Fig. 2; the primers are listed in Table 1). Primers 2 and 3
overlap, as do primers 4 and 5. A second round of PCR amplification using a
mixture of fragments A, B, and C and primers 1 and 6 only yielded a 1.8-kp
product. Transformation of strain 26695 with this product and selection for
erythromycin resistance resulted in replacement of mdaB with the mdaB-erm
allele.
The C. jejuni rpsL gene was inserted upstream of erm in the mdaB-erm allele
to generate the 1.5-kb rpsL,erm cassette (Fig. 1). This was achieved by amplifi-
cation of three PCR products and their assembly into a composite PCR product
(again as in Fig. 2 and Table 1), use of this product to transform strain 26695-str,
selection of Ermr transformant colonies, and identification of those products that
had become phenotypically Strs. In terms of the depiction in Fig. 2, fragment A
contained sequences just upstream of erm in the mdaB-erm allele; fragment C
contained erm and also H. pylori sequences downstream of mdaB; and fragment
B contained the Cj.rpsL (strs allele) gene. PCR of the mixture of segments A, B,
and C with primers 1 and 6 yielded the desired 2.5-kb assembly.
Replacements of genes frxA, fur, and nikR with the rpsL,erm cassette were
made similarly by (i) using DNAs from upstream and downstream of these target
genes (amplified with appropriate primers 1 and 2 and primers 5 and 6) and also
from the rpsL,erm cassette (amplified with primers 3 and 4); (ii) assembly from
the three-fragment mixture using the appropriate locus-specific primers 1 and 6
(Table 1); (iii) transformation of 26695-str, selection of Ermr colonies, and
identification of those that were phenotypically Strs; and (iv) verification by PCR
of the replacement of wild-type alleles by the rpsL,erm-marked deletion alleles.
RESULTS
A two-gene (1.5-kb) cassette containing the C. jejuni rpsL
gene (strs allele) upstream of an erythromycin resistance gene
(erm) (Fig. 1), flanked by H. pylori chromosomal sequences
that normally flank the mdaB quinone reductase gene (allele
designated mdaB-rpsL,erm) was constructed by PCR (Fig. 2)
and recovered in the H. pylori chromosome after the transfor-
mation of 26695-str (see Materials and Methods). PCR tests
showed that each of four Ermr Strs transformants tested con-
tained the expected mdaB-rpsL,erm allele in place of the
full-length mdaB gene. Streaks of such colonies to streptomy-
cin-containing agar typically yielded a few Strr derivative col-
onies after prolonged incubation. This slight instability is not
seen in haploid strains containing only an rpsL-strs allele. These
rare Strr derivatives remained Ermr and, based on PCR tests,
retained the mdaB-rpsL,erm allele in place of mdaB. These
derivatives likely result from occasional gene conversion, de-
spite H. pylori-C. jejuni rpsL sequence divergence.
In initial characterizations, nine recipient populations, each
representing a different Strs mdaB-rpsL,erm transformant of
26695-str, were used for transformation with genomic DNAs
from wild-type 26695. About 30 Strr colonies from each trans-
formation were streaked with toothpicks to erythromycin-con-
taining agar: between 63 and 96% of Strr colonies obtained
FIG. 2. Construction of insertion and deletion alleles by assembly
of three fragments with overlapping ends. Half arrows indicate the
positions of the primers, whose sequences are given in Table 1. Seg-
ments A and C represent DNA segments flanking the locus to be
deleted or the site of insertion (depending on needs of experiment).
Segment B represents (i) the erm (resistance) gene used initially to
replace the mdaB locus; (ii) the rpsL streptomycin susceptibility gene
from C. jejuni that was inserted just upstream of erm in a strain
carrying erm in place of mdaB; or (iii) the rpsL,erm cassette, which can
be moved to many loci.
TABLE 1—Continued
Process Primera Sequence (5-3)b Product size and/or comments
fur-rpsL,erm allele construction
(replacement of fur with
rpsL,erm cassette)
1. x5k-F CCTTAATTTAGCCGCTTCTTGTTTG-3 553 bp
2. fur-R-A2 AAGTGTTTAATCCATAGTTATAAAGCATC
CTGATATCTTCCTTATCCGTA-3
3. rpsL-F-1 GATGCTTTATAACTATGGATTAAACAC-3 1,539 bp
4. erm-R TTACTTATTAAATAATTTATAGCTATTGAA-3




All The 5 ends of the primers are as follows: primer 1,
554 bp upstream of the fur 5 end; primer 2, 2 bp
upstream of the fur 5 end; primer 5, 18 bp
downstream of the fur 3 end; primer 6, 471 bp
downstream of the fur 3 end; the PCR products
with primers 1 and 6 are 1,478 and 2,546 bp long
from the wild-type and frxA-rpsL,erm DNAs,
respectively
a Generic primer designations 1, 2, 3, 4, 5, and 6 for the construction of insertion and deletion alleles are as diagrammed in Fig 2.
b The portions of the primer sequences in italics constitute complement with another primer (primer 2 with primer 3 or vice versa and primer 4 with primer 5 or vice
versa); the portions of these hybrid primers in boldface indicate regions matching the H. pylori genomic DNA used for amplification. All, primers 1 to 6.
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were Erms (average, 84%  13%) (Table 2). PCR tests con-
firmed mdaB-rpsL,erm replacement by full-length mdaB in
each of eight Strr Erms colonies tested, and retention of
mdaB-rpsL,erm in four Strr Ermr colonies, as expected (Fig. 3).
In related tests, PCR products containing full-length mdaB
plus several hundred base pairs of flanking sequences (made
with mdaB primers 1 and 6; Table 1) were used in equivalent
transformations of mdaB-rpsL,erm derivatives of 26695-str or
isogenic metronidazole-resistant strains (mutation in mdaB is
implicated in the development of high-level metronidazole resis-
tance [2]). Approximately 30 to 86% of the Strr colonies obtained
(average of 68%; ten transformations) were of the desired
Erms type.
To test the generality of this allele replacement strategy, the
mdaB-rpsL,erm allele was moved by transformation into the
streptomycin-resistant (rpsL) strains SS1-str, G27MA-str, and
X47 by using genomic DNA from 26695-str mdaB-rpsL,erm
and selection for erythromycin resistance. Each of the 30
Ermr transformants in each of these strains were Strs, as ex-
pected. Two mdaB-rpsL,erm derivatives of each strain, found
by PCR to have the expected structure, were used as recipients
in transformations with DNA from isogenic wild-type parents.
Table 2 shows that the yields of Strr Erms transformants among
Strr colonies ranged from 21% in the case of G27MA-str to
88% in the case of X47.
To further test the general utility of this contraselection
strategy, we constructed deletion alleles marked with the
rpsL,erm cassette of three other genes—frxA (nitroreductase),
fur (iron- and pH-responsive regulation), and nikR (nickel-
responsive regulation)—by PCR (Fig. 2) and transformation of
26695-str (Materials and Methods). DNAs from transformants
with the desired Strs phenotypes and PCR-verified structures
were then used to move each rpsL,erm-tagged deletion allele to
the three other strains (G27MA-str, SS1-str, and X47). The
yields of Ermr Strs transformants among Ermr colonies made
with these genomic DNAs varied from 50% to 100% (data
not shown). Since just one genomic DNA preparation for each
locus was used to move a given allele among H. pylori strains
(in each case from the 26695-str derivative), this variation in
Strs colony yield might reflect an interplay of the strain back-
ground (e.g., nuclease or DNA repair activities) and the se-
quence of the transforming DNA and/or the targeted region.
These new rpsL,erm-marked strains were then transformed
with isogenic wild-type genomic DNAs, and Strr colonies were
selected and tested as described above. Table 2 shows that the
yields of Erms Strr transformants among Strr colonies varied
with the locus under study (from17% to90%) and with the
strain background. PCR tests of a few representative Strr Erms
transformants of each of these various rpsL,erm-marked dele-
FIG. 3. Strategy for the use of rpsL from C. jejuni as a contraselectable determinant of streptomycin susceptibility in H. pylori. Diagrammed here
is a recipient strain carrying an strr allele of its normal (H. pylori) rpsL gene and also the rpsL,erm cassette that had (in an earlier transformation)
replaced the mdaB gene, now being transformed with genomic DNA from a strain with full-length mdaB, and acquisition of mdaB plus flanking
sequences by crossing over in regions of sequence homology. This results in replacement of the rpsL,erm cassette and a change from Ermr to Erms
in phenotype. Unwanted gene conversion events also result in an Strr phenotype, but the Ermr phenotype is retained.






Yield of Strs Ermr (rpsL,erm) derivative of recipient strain  SD:
26695-str SS1-str X47 G27MA-str
mdaB 0.84  0.13 (9) 0.40  0.10 (2) 0.88  0.14 (2) 0.21  0.14 (4)
frxA 0.53  0.22 (10) 0.90  0.04 (2) 0.87  0.03 (2) 0.17  0.15 (4)
fur 0.28  0.3 (8) 0.22  0.11 (2) 0.71  0.03 (2) 0.56  0.26 (4)
nikR 0.54  0.42 (2) 0.86  0.18 (2) 0.96  0.02 (2) 0.38  0.35 (4)
a Average fraction of Strr colonies  standard deviation that were Erms after
transformation of the indicated rspL,erm cassette containing recipient strain with
isogenic wild-type genomic DNA. These Erms colonies were products of trans-
formation and replacement of the contraselectable cassette, not gene conversion.
These fractions are based on erythromycin resistance tests of approximately 30
colonies per transformation experiment. Listed in parentheses are the numbers
of independent transformations, each with a different single colony isolate of the
indicated recipient strain.
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tion strains verified the expected replacement of the rpsL,erm
allele in each case.
DISCUSSION
We constructed a two-gene cassette containing an erm (re-
sistance) gene for selection and a C. jejuni rpsL gene (domi-
nant streptomycin susceptibility; ribosomal protein S12) that is
18% divergent from H. pylori rpsL for contraselection. Each
rpsL,erm-marked allele was first made by transformation of a
PCR product into one strain and then moved to other strains
by transformation with genomic DNA from this first PCR-
verified transformant. In the future such strains might equally
be generated using PCR products to strictly limit the amount
of DNA adjacent to the rpsL,erm cassette that is acquired
during transformation. It would also eliminate any risk of the
acquisition of unlinked genes (although this was not a major
concern here because simultaneous transformation for two
unlinked markers is rare).
Our results with four rpsL,erm-marked loci in four unrelated
strains suggest that this cassette can be placed at any nones-
sential site in H. pylori strains of interest. Once inserted, other
DNAs can be moved to that marked locus by transformation
and homologous recombination. The desired transformants
are identified simply by screening a relatively few Strr colonies
to identify those with the desired Erms phenotype. The yields
of these replacements among selected Strr colonies varied
from 17% to 90%, depending on the gene targeted and the
strain background. That this variation was seen with genomic
DNAs from isogenic wild-type donor strains indicates that it is
not due to DNA restriction. Rather, it may reflect local and
genomewide effects on relative efficiencies of transformation
versus gene conversion between related but divergent se-
quences. If further improvement in efficiency were needed, this
could likely be achieved with a synthetic rpsL gene that is even
more divergent from the H. pylori rpsL in DNA sequence (to
further inhibit gene conversion), while exploiting the degener-
acy of the code to ensure that it still encodes an H. pylori-like
S12 protein.
In other experiments to date, we used this rpsL,erm cassette
to replace point mutant alleles with wild-type alleles and vice
versa, to replace full-length genes with unmarked deletion
alleles, and to create a novel triple mutant allele of the fur
regulatory gene (itself generated by PCR without cloning) for
functional analyses of iron and pH-responsive transcriptional
regulation. We anticipate additional applications for this cas-
sette, including (i) the functional characterization of genes
from divergent clinical isolates; (ii) altering key regulatory
sites; (iii) engineering new domains or epitopes in surface-
exposed or -secreted proteins; (iv) adding new genes to ge-
nomes of interest; and (v) deletion or other changes in some or
all members of multigene families, unimpeded by the numbers
of changes that might be needed.
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